This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Postmortem on Regulatory Misdirection

John W. Lundquist, JD

Arch Surg. 1996;131(9):911-914.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE RECENT prosecution and acquittal of well-known transplantation surgeon John S. Najarian, MD, of the University of Minnesota at Minneapolis has renewed controversy concerning how the Food and Drug Administration (FDA) functions. At the conclusion of the trial, the presiding federal judge took the unusual step of publicly criticizing the FDA for its decision to file criminal charges based on conduct that the court believed the FDA had been aware of for some 20 years. The poor oversight and decisions by the FDA in this case, coupled with its enormous influence on academic institutions, has further strained the relationship between regulators and academic medicine.

CASE HISTORY

On August 13, 1992, the deputy director of the FDA's Center for Biologic Evaluation and Research traveled to Minneapolis, Minn, to personally deliver a letter to University of Minnesota President Nils Hasselmo and Department of Surgery chairperson, Dr Najarian. This letter closed down the . . . [Full Text PDF of this Article]

Author Affiliations
Minneapolis, Minn

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?